Financial intelligence for Asia's healthcare markets
 
 
Remember me:



News

Diversified conglomerate Mexter Technology is raising M$14.3 million (US$3.2 million) via a private placement to fund its expansion into healthcare services. It is selling up to 20% of its share capital. M&A Securities is handling the deal.
Harmonicare Medical, the largest private obstetrics and gynaecology specialty hospital group in China, has reported a 9.9% decline in profits for 2016 to Rmb95.7 million (US$13.9 million). At the same time, revenues slipped 5.5% to Rmb859.7 million.
Medical device manufacturer Vincent Medical has reported a 48.2% slump in annual profits to HK$37.1 million (US$4.8 million). At the same time, revenues for the year were up 4.3% to HK$467.3 million.
Chinese medical products conglomerate Shandong Weigao Group Medical Polymer has reported a 17.6% rise in profits for 2016 to Rmb1.3 billion (US$188.9 million) on revenues that were up 13.7% to Rmb6.7 billion.
Anand Kumar has been appointed a non-independent non-executive director of SGX-listed healthcare provider Healthway Medical Corporation (HMC). This follows the news last week that HMC had been thrown a lifeline after agreeing to a revised convertible notes deal with Singapore and Dubai based private equity firm Gateway Partners.
SGX-listed healthcare provider Healthway Medical Corporation (HMC) has been thrown a lifeline after agreeing to a revised convertible notes deal with Singapore and Dubai based private equity firm Gateway Partners.
The Australian Competition and Consumer Commission has decided not to oppose the acquisition of private hospital operator Pulse Health by Healthe Care, Australia’s third largest hospital operator.
Guangdong Kanghua Healthcare, the operator of the largest private hospital in China, has reported a 22.5% rise in profits for 2016 to Rmb145.7 million (US$21.2 million). At the same time, revenues rose 16.6% to Rmb1.2 billion.



Analysis

The takeover of Australian private hospital operator Pulse Health by Healthe Care, Australia’s third largest hospital operator has been put on hold for two months. Yesterday Pulse applied to the Supreme Court of New South Wales to delay a scheme meeting planned for Wednesday this week to approve its takeover, until 1 May.
The renounceable non-underwritten 11-for-200 rights issue for SGX-listed private healthcare provider Health Management International (HMI) has received strong interest from investors. It had a 145.7% subscription rate, raising gross proceeds of S$18.5 million (US$13.1 million).
Timothy Low, chief executive officer of Farrer Park Hospital in Singapore, explains how high end medical treatment can find its niche as belts around the region are tightened.
Michael Custer, analyst at Solidiance in Shanghai, explains that healthcare service providers will come out on top from China’s healthcare reforms.
Asia is no longer the benign liability environment that it once was. Michael Griffiths, regional director of healthcare at Aon Singapore, explains why.
Rhenu Bhuller, partner at Frost & Sullivan, examines the evolving implications of the Trump election on the healthcare industry in Asia.
Healthcare Partners has increased its hostile takeover bid for NZX-listed specialist medical investment firm Abano Healthcare Group. It is now offering NZ$10.16 per share (US$7.34) per share, up from NZ$10.00 per share. The increased offer takes into account the dividend that Abano paid last month.
Real estate group OUE has made a S$62.9 million (US$44.4 million) takeover bid for financially troubled International Healthway Corporation (IHC), a Singapore-listed integrated healthcare services and facilities provider.


HealthInvestor Asia twitter feed


Markets

Markets in Asia were initially sanguine about the failure of US president Donald Trump to repeal the 2010 Affordable Care Act – better known as Obamacare – on Friday. “Stocks don’t seem to be too worried yet. And the reality is I’ll be guided by the price action in my trading,” said Greg McKenna, chief market strategist at AxiTrader in Sydney at the open this morning. But the shine came off the Trump rally as the day went on and markets began to stumble. The most obvious consequence came from a weakening US dollar that saw the Nikkei fall 1.51%. Other regional markets followed it lower. The ASX was down 0.14%, the Hang Seng gave up 0.28% and the SGX fell 0.50%, though many of the trades appeared to be profit taking as we head towards the end of the first quarter.


IFC


HealthInvestor Asia Summit 2016

Round table




Subscribe

Analysis


The Future of Healthcare in Asia

Round table

Download the round table here




HealthInvestor UK